A Prospective, Interventional, Multicentre, Post-marketing Clinical Study of a fixed-dose combination of Paracetamol (125 mg), Phenylephrine HCL (5 mg), Chlorpheniramine Maleate (1 mg) and Sodium Citrate (60 mg/5 mL) for the Treatment of Common Cold and Flu Syndrome in Children

dc.contributor.authorKumar, Pankajen_US
dc.contributor.authorMenezes, Rashmien_US
dc.contributor.authorPinto, Vinayen_US
dc.contributor.authorArora, Deepaken_US
dc.contributor.authorJayseela, Karunrajen_US
dc.contributor.authorKumar, Sumiten_US
dc.contributor.authorRajdeo, Dipeshhen_US
dc.contributor.authorS, Harishen_US
dc.contributor.authorZ, Vindaen_US
dc.contributor.authorD, Tapasen_US
dc.date.accessioned2023-06-17T08:35:25Z
dc.date.available2023-06-17T08:35:25Z
dc.date.issued2022-10
dc.description.abstractBackground : Common cold is an acute, self-limiting viral infection of the upper respiratory tract involving the nose, sinuses, pharynx, and larynx. According to various studies, the combination of analgesics, decongestants, and antihistamines provides better relief for multiple symptoms in the common cold. Fixed dose combination of Paracetamol as an analgesic, anti-inflammatory, and antipyretic, Chlorpheniramine maleate, an anti-histaminic, and Phenylephrine as a nasal decongestant is primarily used in the treatment of the common cold. Hence the present post-marketing surveillance study was planned to find any unwanted adverse effects and efficacy of commercially available combination in treating the common cold in children. Methodology : The prospective, single-arm, multicenter, post-marketing clinical study included 224 children from four different study sites, of which 204 completed the study. Subjects were given this fixed dose combination for three days and then monitored for the next six days. During the study, the efficacy was evaluated using VAS score changes from the beginning to the end of the treatment. Incidence of Adverse Events (AE) and Serious Adverse Events (SAE) was assessed. The product's safety was also evaluated using blood biomarkers such as Hemoglobin, Platelet count, SGOT, SGPT, and creatinine level. Results : The reduction in symptomatic score of common cold and flu syndrome was observed after 3rd followup visit [(0.384±0.168 (visit 1) to 0.001±0.009 (Visit 3), (p<0.001)]. No intervention-related or serious adverse events (SAE) were observed in the study or follow-up period. The study found no major changes in the levels of haemoglobin, platelets, SGOT, SGPT, and creatinine. Conclusions : Fixed-dose combination of Paracetamol (125 mg), Phenylephrine HCL (5 mg), Chlorpheniramine Maleate (1 mg) and Sodium Citrate (60 mg/5 mL) is safe and effective in treating children's common cold and flu syndrome.en_US
dc.identifier.affiliationsWallace Pharmaceuticals Pvt Ltden_US
dc.identifier.affiliationsICBio Clinical Research Pvt Ltd, *Corresponding Authoren_US
dc.identifier.citationKumar Pankaj, Menezes Rashmi, Pinto Vinay, Arora Deepak, Jayseela Karunraj, Kumar Sumit, Rajdeo Dipeshh, S Harish, Z Vinda, D Tapas. A Prospective, Interventional, Multicentre, Post-marketing Clinical Study of a fixed-dose combination of Paracetamol (125 mg), Phenylephrine HCL (5 mg), Chlorpheniramine Maleate (1 mg) and Sodium Citrate (60 mg/5 mL) for the Treatment of Common Cold and Flu Syndrome in Children. Journal of The Indian Medical Association. 2022 Oct; 120(10): 71-75en_US
dc.identifier.issn0019-5847
dc.identifier.placeIndiaen_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/216621
dc.languageenen_US
dc.publisherIndian Medical Associationen_US
dc.relation.issuenumber10en_US
dc.relation.volume120en_US
dc.source.urihttps://www.onlinejima.com/read_journals.php?article=1041en_US
dc.subjectCommon colden_US
dc.subjectFlu syndromeen_US
dc.subjectChildren.en_US
dc.titleA Prospective, Interventional, Multicentre, Post-marketing Clinical Study of a fixed-dose combination of Paracetamol (125 mg), Phenylephrine HCL (5 mg), Chlorpheniramine Maleate (1 mg) and Sodium Citrate (60 mg/5 mL) for the Treatment of Common Cold and Flu Syndrome in Childrenen_US
dc.typeJournal Articleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
JIMA2022v120n10p71.pdf
Size:
136.7 KB
Format:
Adobe Portable Document Format